Arbet-Engels Christophe 4
4 · X4 Pharmaceuticals, Inc · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Arbet-Engels Christophe
Chief Medical Officer
Transactions
- Award
Stock Appreciation Right
2024-02-13+475,831→ 475,831 totalExercise: $0.92Exp: 2034-02-13→ Common Stock (475,831 underlying)
Footnotes (1)
- [F1]The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of February 13, 2024, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date.